GLI1
GLI1 (Transcription activator GLI1) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Sarcomas and Leiomyosarcoma.
Overview
Transcription activator that acts as a key effector of the smoothened signalling pathway, and which plays a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract. Binds to the DNA consensus sequence 5'-GACCACCCA-3'. Activated in response to smoothened signalling: in presence of hedgehog (DHH, IHH or SHH) and subsequent activation of smoothened, GLI1 translocates to the nucleus and promotes expression of target genes.
IntOGen calls it a driver in 1 cohort (0 activating, 1 loss-of-function), covering Leiomyosarcoma.
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · GLI1 (Transcription activator GLI1) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Sarcomas and Leiomyosarcoma.
- 1 · What it is
GLI1 (Transcription activator GLI1) is a gene whose normal job is to hold cell growth in check. The public catalogues list it as a tumour suppressor, and it is called a cancer driver by mutation analysis of patient cohorts. Tied to Sarcomas and Leiomyosarcoma.
- 2 · What goes wrong in cancer
Transcription activator that acts as a key effector of the smoothened signalling pathway, and which plays a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract.
- 3 · How drugs use it
No product in this corpus aims at GLI1 yet. Because the protein is lost rather than overactive, drugs either restore its function or exploit the weakness its loss leaves (synthetic lethality).
External identifiers
Sources: HGNC HGNC:4317 (approved symbol, name, aliases, locus and cross-references (hgnc_complete_set.txt)); UniProt P08151 (protein name, function text, keywords and locations (REST API)); IntOGen GLI1 (driver in 1 cohort (Act 0, LoF 1); Compendium_Cancer_Genes.tsv release 20240920, CC0 1.0)
Biology
Transcription activator that acts as a key effector of the smoothened signalling pathway, and which plays a role in craniofacial development and digital development, as well as development of the central nervous system and gastrointestinal tract. Binds to the DNA consensus sequence 5'-GACCACCCA-3'. Activated in response to smoothened signalling: in presence of hedgehog (DHH, IHH or SHH) and subsequent activation of smoothened, GLI1 translocates to the nucleus and promotes expression of target genes. In contrast to GLI2 and GLI3, does not contain a repressor domain and only acts as a transcription activator. Acts as a transcriptional activator, but activates a different set of genes than isoform 1. Activates expression of CD24, unlike isoform 1. Location: Cytoplasm; Nucleus; Cell projection, cilium (UniProt). Locus 12q13.3 (HGNC).
- Sarcomas: IntOGen driver in 1 cohort (LMS)
- Leiomyosarcoma: IntOGen driver in 1 cohort (LMS)
Notes
top- Written by scripts/fetch-cancer-genes.ts from CIViC, Open Targets, IntOGen, HGNC and UniProt; the function text is UniProt's, condensed and in UK spelling. Roles: IntOGen calls it a loss-of-function (LoF) driver in 1 cohort. Evidence tier "cohort-driver" is the strongest of those signals.
- Prevalence not recorded: none of the sources gives a positivity rate.
Latest papers
topQuery for this target: (TITLE:"GLI1" OR ABSTRACT:"GLI1" OR TITLE:"GLI family zinc finger 1" OR ABSTRACT:"GLI family zinc finger 1" OR TITLE:"Transcription activator GLI1" OR ABSTRACT:"Transcription activator GLI1") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about GLI1, not a curated reading list.
Similar pages
not linked directly; found by shared links- TargetDDX6
Shares Leiomyosarcoma, Sarcomas (soft tissue, bone, GIST), IntOGen.
- TargetWNK2
Shares Leiomyosarcoma, Sarcomas (soft tissue, bone, GIST), IntOGen.
- TargetCAMTA1
Shares Leiomyosarcoma, Sarcomas (soft tissue, bone, GIST), IntOGen.
- TargetSUFU
Shares Basal cell carcinoma (KEGG map), Hedgehog signalling, IntOGen.
- TargetUSP9X
Shares Leiomyosarcoma, Sarcomas (soft tissue, bone, GIST), IntOGen.
- PersonPatrick Schöffski
- PersonPatricia Pautier
- TrialSTRASS (EORTC 62092)